NVR, Inc. (NVR), Masco Corporation (MAS), AeroVironment, Inc. (AVAV): Tuesday’s Top Upgrades (and Downgrades)

Page 1 of 2

This series, brought to you by Yahoo! Finance, looks at which upgrades and downgrades make sense, and which ones investors should act on. Today, our headlines feature a downgrade for homebuilder NVR, Inc. (NYSE:NVR), but an upgrade for Masco Corporation (NYSE:MAS) — and for AeroVironment, Inc. (NASDAQ:AVAV), an increase in price target. Let’s dive right in.

Are homebuilders in trouble?
On the front page of today’s Wall Street Journal, banker Wells Fargo & Co (NYSE:WFC) is quoted warning investors at a banking conference of an impending 28% drop in mortgage originations in Q3. A few lines down, JPMorgan Chase & Co. (NYSE:JPM) chimes in with its own worries that it’s likely to lose money on mortgage originations in this year’s second half.

NVR, Inc. (NYSE:NVR)

And continuing the theme, this morning we learned from StreetInsider.com that Swiss megabanker Credit Suisse has just downgraded homebuilder NVR, Inc. (NYSE:NVR)… to underperform. Credit Suisse hates NVR more than it hates either Beazer or D.R. Horton — two other homebuilders it downgraded today, but only to neutral. It likes NVR, Inc. (NYSE:NVR) a whole lot less than rival M.D.C. Holdings, the only homebuilder the banker decided to upgrade.

But why would you want to take Credit Suisse’s advice about these stocks?

Let me count the ways. Comparing the two companies at the opposite ends of Credit Suisse’s ratings scale, NVR, Inc. (NYSE:NVR) costs more than 22 times earnings. MDC costs only five times earnings. Valued on their assets, NVR, Inc. (NYSE:NVR) costs more than 3.1 times book value; MDC — less than 1.3. And of course, at the most basic, tangible level, MDC pays its shareholders a generous 3.6% dividend yield… while NVR, Inc. (NYSE:NVR) pays zilch.

If ever an analyst was painting an argument for making a “paired trade,” selling one stock short, and using the money to buy another, similar, but cheaper stock — Credit Suisse appears to be making that case for us today.

Aside from homebuilders, are there other opportunities in housing?
Despite rumors of an impending decline in mortgage originations, all’s not entirely bleak in the homebuilding sector, as Credit Suisse’s upgrade of MDC makes clear. And indeed, other analysts think they see additional opportunities to invest in a housing market that may not be done running just yet. (As we’ll see in a moment, they’re wrong… but still worth considering, just to see what the analysts are saying).

Take cabinetmaker Masco Corporation (NYSE:MAS) for instance. This morning, analysts at Oppenheimer announced an upgrade of Masco shares to outperform, predicting that housing market “tailwinds” will continue, and will help lift the stock to $25 within a year. According to Oppy, “[Channel] checks indicate [that the] positive momentum MAS cited in July … persisted through the summer, setting [the stock] up for a strong 3Q13.” Indeed, even assuming Masco Corporation (NYSE:MAS) fails to achieve its targeted 30% gross margins in 2014 and 2015 (the company’s grossing about 26% right now), Oppenheimer still likes the stock’s chances, as sees the potential for a 20% gain in share price.

But is Oppenheimer right? Can stronger margins, and stronger sales, make Masco Corporation (NYSE:MAS) a buy?

I wish I could say yes, but it’s hard to see how the analyst could be right. Priced at 150 times earnings today, Masco’s stock looks far too overvalued to ever have any chance of outperforming the market. Sure, over the past 12 months, Masco Corporation (NYSE:MAS) generated some $218 million in positive free cash flow from its business, which is more than four times as much cash profit as the $52 million in “net income” the company was allowed to report under GAAP.

Page 1 of 2

Biotech Insider Alert - $6 Stock To Hit $40

$200 Million Dollar Healthcare Hedge Fund's #1 Best Idea Right Now

The best healthcare hedge fund out there right now is one of the largest shareholders in this biotech stock. The fund returned more than 20% in each of the last 2 years with a virtually fully hedged portfolio, and it's sending out a BUY signal on this biotech stock. Get your FREE REPORT today (retail value of $300)

This is a FREE report from Insider Monkey. Credit Card is NOT required.
Comments
Insider Monkey Small Cap Strategy
Insider Monkey Small Cap Strategy

Insider Monkey beat the market by 52 percentage points in 24 months. Our beta is only 1.2 (don't click this link if beating the market isn't important to you).

Lists

The World’s Most Famous Circuses

Best Hair Stylists

Most Popular NASCAR Drivers

The Best Romance Movies of all Time

The Most Wanted Drug Lords

The Oldest Money Managers

The Greatest Directors in the World

Largest Animals in the World

World’s Most Expensive Desserts

Best Selling Comic Books of All Time

A-list Actors who Sabotaged Their Career

Rappers With a College Degree

The Best Jazz Albums of all Time

The Most Influential Jazz Musicians

The World’s Most Famous Photographers

The Best Oscar-Winning Songs

Most Influential Choreographers Ever

Most Expensive Department Stores in the World

The Most Expensive Stolen Paintings in the World

The World’s Most Expensive Teas

Top Oscar Record Holders

The Most Expensive Flowers in the World

Countries With a Booming Film Industry

Most Expensive Cupcakes in the World

Uncommon European Escapes

The Most Stolen Artists in History

Best Travel Destinations in Australia

World’s Most Expensive Musical Instruments

World’s Most Famous Animals

Most Expensive Cakes in the World

Most Expensive Kosher Champagne in the World

Most Expensive Kosher Wine in the World

The Most Surprisingly Dark Fairy Tales

Most Popular Travel Destinations in Asia

The 10 Most Expensive Dresses Ever Worn to the Oscars

World’s Most Visited Art Museums

Best Countries for Photographers to Work in

Best Paid Jobs in the Film Industry

The Most Renowned Recovered Paintings Ever

Child Stars That Turned out Just Fine

Books That Were Banned in the Past Century

World’s Richest Dancers

Best Remedies against Bad Breath

Foods That Improve Your Skin Texture

Best-Selling Children’s Books of all Time

Foods That Boost Your Libido

Best-Selling Books of all Time

The Most Expensive Academy Awards Jewelry in History

Most Expensive Japanese Restaurant In New York City

The Best B-Boy Movies

Subscribe

Enter your email:

Delivered by FeedBurner

X

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 129% in 2.5 years!! Wondering How?

Download a complete edition of our newsletter for free!